A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families

Genome Research

Volumn 9, Issue 6, 1999, Pages 575-580

  Van Der Velden, Pieter A ^a   Sandkuijl, Lodewijk A ^a   Bergman, Wilma ^a   Hille, Elysée T M ^a   Frants, Rune R ^a   Gruis, Nelleke A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CANCER GENETICS; CANCER RISK; CHROMOSOME 9P; CHROMOSOME MARKER; CONGENITAL NEVUS; FAMILIAL CANCER; GENE LOCUS; HAPLOTYPE; HUMAN; MELANOMA; PRIORITY JOURNAL;

ALLELES; ALTERNATIVE SPLICING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DYSPLASTIC NEVUS SYNDROME; FEMALE; GENETIC MARKERS; HETEROZYGOTE DETECTION; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; NETHERLANDS; PEDIGREE; RISK FACTORS;

EID: 0032788149     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bahuau, M., D. Vidaud, R.B. Jenkins, I. Bieche, D.W. Kimmel, B. Assouline, J.S. Smith, B. Alderete, J.M. Cayuela, J.P. Harpey, B. Caille, and M.Vidaud. 1998. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res. 58: 2298-2303.
2. Bergman, W., N.A. Gruis, L.A. Sandkuijl, and R.R. Frants. 1994. Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: A review of linkage results including chromosomes 1 and 9. J. Invest. Dermatol. 103: 122S-125S.
3. Cannon-Albright, L.A., D.E. Goldgar, L.J. Meyer, C.M. Lewis, D.E. Anderson, J.W. Fountain, M.E. Hegi, R.W. Wiseman, E.M. Petty, A.E. Bale et al. 1992. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258: 1148-1152.
4. Gruis, N.A., L.A. Sandkuijl, J.L. Weber, A. van der Zee, A.M. Borgstein, W. Bergman, and R.R. Frants. 1993. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count. Melanoma Res. 3: 271-277.
5. Gruis, N.A., L.A. Sandkuijl, P.A. van der Velden, W. Bergman, and R.R. Frants. 1995a. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res. 5: 169-177.
6. Gruis, N.A., P.A. van der Velden, L.A. Sandkuijl, D.E. Prins, J. Weaver-Feldhaus, A. Kamb, W. Bergman, and R.R. Frants. 1995b. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet. 10: 351-353.
7. Hannon, G.J. and D. Beach. 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261.
8. Harland, M., R. Meloni, N. Gruis, E. Pinney, S. Brookes, N.K. Spurr, A.M. Frischauf, V. Bataille, G. Peters, J. Cuzick, P. Selby, D.T. Bishop, and J.N. Bishop. 1997. Germline mutations of the CDKN2 gene in UK melanoma families. Hum. Mol. Genet. 6: 2061-2067.
9. Hille, E.T., E. van Duijn, N.A. Gruis, F.R. Rosendaal, W. Bergman, and J.P. Vandenbroucke. 1998. Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994. J. Invest. Dermatol. 110: 788-792.
10. Hussussian, C.J., J.P. Streuwing, A.M. Goldstein, P.A.T. Higgins, D.S. Ally, M.D. Sheanan, W.H. Clark Jr., M.A. Tucker, and N.C. Dracopoli. 1994. Germline p16 mutations in familial melanoma. Nat. Genet. 8: 15-21.
11. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day III, B.E. Johnson, and M.H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
12. Kamijo, T., F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.
13. Kamijo, T., J.D. Weber, G. Zambetti, F. Zindy, M.F. Roussel, and C.J. Sherr. 1998. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. 95: 8292-8297.
14. Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
15. Nobori, T., K. Miura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
16. Pollock, P.M., N. Spurr, T. Bishop, J. Newton-Bishop, N. Gruis, P.A. van der Velden, A.M. Goldstein, M.A. Tucker, W.D. Foulkes, R. Barnhill, D. Haber, J. Fountain, and N.K. Hayward. 1998. Haplotype analysis of two recurrent CDKN2A mutations in ten melanoma families: Evidence for common founders and independent mutations. Hum. Mutat. 11: 424-431.
17. Puig, S., A. Ruiz, C. Lazaro, T. Castel, M. Lynch, J. Palou, A. Vilalta, J. Weissenbach, J.M. Mascaro, and X. Estivill. 1995. Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet. 57: 395-402.
18. Rizos, H., T.M. Becker, E.A. Holland, R.F. Kefford, and G.J. Mann. 1997. Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations. Oncogene 15: 515-523.
19. Schork, N.J., B. Thiel, and P. St. Jean. 1998. Linkage analysis, kinship, and the short-term evolution of chromosomes. J. Exp. Zool. 282: 133-149.
20. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
21. Stone, S., P. Jiang, P. Dayananth, S.V. Tavtigian, H. Katcher, D. Parry, G. Peters, and A. Kamb. 1995. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55: 2988-2994.
22. Stott, F.J., S. Bates, M.C. James, B.B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K.H. Vousden, and G. Peters. 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17: 5001-5014.
23. Te Meerman, G.J., M.A. Van der Meulen, and L.A. Sandkuijl. 1995. Perspectives of identity by descent (IBD) mapping in founder populations. Clin. Exp. Allergy (Suppl. 2) 25: 97-102.
24. INK4 gene in Australian melanoma kindreds. Hum. Mol. Genet. 4: 1845-1852.
25. Wiest, J.S., W.A. Franklin, J.T. Otstot, K. Forbey, M. Varella-Garcia, K. Rao, H. Drabkin, R. Gemmill, S. Ahrent, D. Sidransky, G. Saccomanno, J.W. Fountain, and M.W. Anderson. 1997. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res. 57: 1-6.